Richard J. Benjamin, MD PhD FRCPath

Cerus Corporation, Concord, CA, USA

Poster(s):

• (P-TS-24) Design of ReCePI, a Randomized, Double-Blinded, Phase III Study to Evaluate the Efficacy and Safety of Pathogen Reduced RBCs in Complex Cardiac Surgery
  Saturday, October 14, 2023

• (P-TS-25) Developing a Tool to Assess Red Blood Cell Clearance in Vivo Utilizing Pathogen-Reduced RBCs
  Saturday, October 14, 2023